Detalhe da pesquisa
1.
Mycobacterial phosphodiesterase Rv0805 is a virulence determinant and its cyclic nucleotide hydrolytic activity is required for propionate detoxification.
Mol Microbiol;
119(4): 401-422, 2023 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36760076
2.
Temporal Analysis of Serial Donations Reveals Decrease in Neutralizing Capacity and Justifies Revised Qualifying Criteria for Coronavirus Disease 2019 Convalescent Plasma.
J Infect Dis;
223(5): 743-751, 2021 03 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33417696
3.
Neutralizing Antibody Responses in COVID-19 Convalescent Sera.
J Infect Dis;
223(1): 47-55, 2021 01 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33104179
4.
Small RNA Mcr11 requires the transcription factor AbmR for stable expression and regulates genes involved in the central metabolism of Mycobacterium tuberculosis.
Mol Microbiol;
113(2): 504-520, 2020 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31782837
5.
Small-Molecule Antibiotics Inhibiting tRNA-Regulated Gene Expression Is a Viable Strategy for Targeting Gram-Positive Bacteria.
Antimicrob Agents Chemother;
65(1)2020 12 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33077662
6.
Novel structural features drive DNA binding properties of Cmr, a CRP family protein in TB complex mycobacteria.
Nucleic Acids Res;
46(1): 403-420, 2018 01 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29165665
7.
AbmR (Rv1265) is a novel transcription factor of Mycobacterium tuberculosis that regulates host cell association and expression of the non-coding small RNA Mcr11.
Mol Microbiol;
110(5): 811-830, 2018 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30207611
8.
Chemical activation of adenylyl cyclase Rv1625c inhibits growth of Mycobacterium tuberculosis on cholesterol and modulates intramacrophage signaling.
Mol Microbiol;
105(2): 294-308, 2017 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28464471
9.
Characterization of a cAMP responsive transcription factor, Cmr (Rv1675c), in TB complex mycobacteria reveals overlap with the DosR (DevR) dormancy regulon.
Nucleic Acids Res;
44(1): 134-51, 2016 Jan 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26358810
10.
Role of intragenic binding of cAMP responsive protein (CRP) in regulation of the succinate dehydrogenase genes Rv0249c-Rv0247c in TB complex mycobacteria.
Nucleic Acids Res;
43(11): 5377-93, 2015 Jun 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25940627
11.
Combined Bioinformatic and Rational Design Approach To Develop Antimicrobial Peptides against Mycobacterium tuberculosis.
Antimicrob Agents Chemother;
60(5): 2757-64, 2016 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26902758
12.
Conditional protein splicing of the Mycobacterium tuberculosis RecA intein in its native host.
bioRxiv;
2024 Apr 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38659745
13.
Quantitating SARS-CoV-2 Neutralizing Antibodies from Human Dried Blood Spots.
bioRxiv;
2024 Apr 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38562708
14.
Identification and characterization of small RNAs in Yersinia pestis.
RNA Biol;
10(3): 397-405, 2013 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23324607
15.
Dysregulation of serine biosynthesis contributes to the growth defect of a Mycobacterium tuberculosis crp mutant.
Mol Microbiol;
82(1): 180-98, 2011 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21902733
16.
Cyclic AMP signalling in mycobacteria: redirecting the conversation with a common currency.
Cell Microbiol;
13(3): 349-58, 2011 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21199259
17.
Multiple small RNAs identified in Mycobacterium bovis BCG are also expressed in Mycobacterium tuberculosis and Mycobacterium smegmatis.
Nucleic Acids Res;
38(12): 4067-78, 2010 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20181675
18.
Pharmacokinetics of convalescent plasma therapy in a COVID-19 patient with X-linked Agammaglobulinemia.
Clin Immunol Commun;
2: 57-61, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38620871
19.
Phenotypic and genetic changes associated with the seesaw effect in MRSA strain N315 in a bioreactor model.
J Glob Antimicrob Resist;
28: 249-253, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35085792
20.
Mucosal nanobody IgA as inhalable and affordable prophylactic and therapeutic treatment against SARS-CoV-2 and emerging variants.
Front Immunol;
13: 995412, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36172366